✦ LIBER ✦

Lipid-Lowering Medication and Risk of Cancer

✍ Scribed by Jørgen H. Olsen; Christoffer Johansen; Henrik Toft Sørensen; Joseph K. McLaughlin; Lene Mellemkjær; Flemming Hald Steffensen; Joseph F. Fraumeni Jr.

Book ID: 117598209
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 142 KB
Volume: 52
Category: Article
ISSN: 0895-4356
DOI: 10.1016/s0895-4356(98)00147-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipid-Lowering Medication and Risk of In

Lipid-Lowering Medication and Risk of Injury

✍ Viktor E. Bovbjerg; David S. Siscovick; Bruce M. Psaty; Barbara S. McCann; Thoma 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Lipid-lowering drugs and risk for cancer

✍ Terje R. Pedersen 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 315 KB

Plasma cholesterol, lipid lowering, and

Plasma cholesterol, lipid lowering, and risk for cancer

✍ Lackner, K. J. ;Schettler, G. ;Kübler, W. 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 828 KB

Lipid lowering, statins and cancer

✍ A. S. Wierzbicki 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB

Lipid-lowering agents and risk of melano

Lipid-lowering agents and risk of melanoma

✍ Robert S. Kirsner; Claudia C. Ramirez; Daniel G. Federman; Fangchao Ma 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 39 KB

A Population-Based Cohort Study'' published in the 1 December edition of the International Journal of Cancer, in which Friis et al. reported a reduction of cancer risk in statins users. Other studies have suggested that statins and other lipid-lowering agents (in contrast to the findings of Friis et

Intervention to Improve Adherence to Lip

Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk

✍ Pythia T. Nieuwkerk; Melchior C. Nierman; Maud N. Vissers; Mirjam Locadia; Phill 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 321 KB